Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
The recent evolution in immunosuppression therapy has led to significant improvement in short-term kidney allograft outcomes; however, this progress did not translate into similar improvement in long-term graft survival.The latter, at least in part, is read more likely to be attributed to immunosuppressant side effects.In this review, we focus on t